Printable Page Headline News   Return to Menu - Page 1 2 3 5 6 7 8 13
 
 
US Stocks Open Higher on Vaccine Hopes 11/23 09:45

   Stocks rose in early trading Monday after investors received several pieces 
of encouraging news on COVID-19 vaccines and treatments, tempering concerns 
over rising virus cases and business restrictions.

   NEW YORK (AP) -- Stocks rose in early trading Monday after investors 
received several pieces of encouraging news on COVID-19 vaccines and 
treatments, tempering concerns over rising virus cases and business 
restrictions.

   The benchmark S&P 500 index rose 0.6%, led by technology companies that have 
been posting solid gains throughout the virus pandemic. Many companies and 
sectors that have been beaten down by the virus, including cruise lines and 
banks, were also among winners.

   The Dow Jones Industrial Average gained 237 points, or 0.8%, at 29,500 as of 
10:08 a.m. Eastern time. The Nasdaq composite rose 0.3%.

   The gains were broad, with more than 80% of the stocks in the S&P 500 
rising. The Russell 2000 index of smaller stocks rose 1% in yet another signal 
that investors were feeling confident. The yield on the 10-year Treasury rose 
to 0.85% from 0.81% late Friday.

   Cruise line operator Carnival rose 2.2% and hotel company Marriott gained 
1.8%. JPMorgan Chase rose 1.9%

   AstraZeneca is the latest drug developer to report surprisingly good results 
from ongoing vaccine studies. It said the potential vaccine, which is being 
developed with partner Oxford University, was up to 90% effective. Unlike rival 
candidates, however, AstraZeneca's doesn't have to be stored at ultra-cold 
temperatures, making it easier to distribute.

   Last week, Pfizer and Moderna both reported study results showing their 
vaccines were almost 95% effective. And, over the weekend, Regeneron 
Pharmaceuticals has received U.S. government approval for emergency use of its 
COVID-19 treatment. The drug, which President Donald Trump received when he was 
sickened last month, is meant to try to prevent hospitalization and worsening 
disease from developing in patients with mild-to-moderate symptoms.

   The latest vaccine developments are helping to raise hopes that some 
normalcy will eventually be restored to everyday life and economic activity. It 
is also tempering lingering concerns about new government controls as the virus 
spikes in the U.S. and globally.

   In Europe, France's CAC 40 rose 0.3%, and Germany's DAX returned 0.4%. The 
FTSE 100 in London was flat. Asian stocks were mixed. Japan's Nikkei 225 fell 
1.1%, but other markets were stronger. South Korea's Kospi added 0.3%, Hong 
Kong's Hang Seng climbed 0.5% and stocks in Shanghai added 0.2%.

 
"Central States Commodities, INC. is a registered trademark. All rights reserved. Central States Commodities, INC. is a Guaranteed Introducing Broker of R.J. O'Brien. Past performance is not necessarily indicative of future performance. The risk of loss in trading futures contracts or commodity options can be substantial, and therefore investors should understand the risks involved in taking leveraged positions and must assume responsibility for the risks associated with such investments and for their results."
 
Copyright DTN. All rights reserved. Disclaimer.
Powered By DTN